Researchers discovered a vulnerability in the hepatitis B virus (HBV) that could lead to new treatments. They found that CBL137, a cancer drug, blocks the virus’s...
VBI Vaccines is a Massachusetts-based biotech company that has a hepatitis B vaccine that's already approved, and selling in fifteen countries right now.